EP3592423A1 - Verfahren zur behandlung von beckenschmerzen, chronischer prostatitis und/oder symptomen einer überaktiven blase - Google Patents

Verfahren zur behandlung von beckenschmerzen, chronischer prostatitis und/oder symptomen einer überaktiven blase

Info

Publication number
EP3592423A1
EP3592423A1 EP17899773.0A EP17899773A EP3592423A1 EP 3592423 A1 EP3592423 A1 EP 3592423A1 EP 17899773 A EP17899773 A EP 17899773A EP 3592423 A1 EP3592423 A1 EP 3592423A1
Authority
EP
European Patent Office
Prior art keywords
probe
laser energy
laser
vagina
tissue
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
EP17899773.0A
Other languages
English (en)
French (fr)
Other versions
EP3592423A4 (de
Inventor
Ralph ZIPPER
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of EP3592423A1 publication Critical patent/EP3592423A1/de
Publication of EP3592423A4 publication Critical patent/EP3592423A4/de
Pending legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61NELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N5/00Radiation therapy
    • A61N5/06Radiation therapy using light
    • A61N5/0601Apparatus for use inside the body
    • A61N5/0603Apparatus for use inside the body for treatment of body cavities
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61HPHYSICAL THERAPY APPARATUS, e.g. DEVICES FOR LOCATING OR STIMULATING REFLEX POINTS IN THE BODY; ARTIFICIAL RESPIRATION; MASSAGE; BATHING DEVICES FOR SPECIAL THERAPEUTIC OR HYGIENIC PURPOSES OR SPECIFIC PARTS OF THE BODY
    • A61H19/00Massage for the genitals; Devices for improving sexual intercourse
    • A61H19/40Devices insertable in the genitals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61HPHYSICAL THERAPY APPARATUS, e.g. DEVICES FOR LOCATING OR STIMULATING REFLEX POINTS IN THE BODY; ARTIFICIAL RESPIRATION; MASSAGE; BATHING DEVICES FOR SPECIAL THERAPEUTIC OR HYGIENIC PURPOSES OR SPECIFIC PARTS OF THE BODY
    • A61H21/00Massage devices for cavities of the body, e.g. nose, ears and anus ; Vibration or percussion related aspects A61H23/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61NELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N5/00Radiation therapy
    • A61N5/06Radiation therapy using light
    • A61N5/067Radiation therapy using light using laser light
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61HPHYSICAL THERAPY APPARATUS, e.g. DEVICES FOR LOCATING OR STIMULATING REFLEX POINTS IN THE BODY; ARTIFICIAL RESPIRATION; MASSAGE; BATHING DEVICES FOR SPECIAL THERAPEUTIC OR HYGIENIC PURPOSES OR SPECIFIC PARTS OF THE BODY
    • A61H2201/00Characteristics of apparatus not provided for in the preceding codes
    • A61H2201/10Characteristics of apparatus not provided for in the preceding codes with further special therapeutic means, e.g. electrotherapy, magneto therapy or radiation therapy, chromo therapy, infrared or ultraviolet therapy
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61HPHYSICAL THERAPY APPARATUS, e.g. DEVICES FOR LOCATING OR STIMULATING REFLEX POINTS IN THE BODY; ARTIFICIAL RESPIRATION; MASSAGE; BATHING DEVICES FOR SPECIAL THERAPEUTIC OR HYGIENIC PURPOSES OR SPECIFIC PARTS OF THE BODY
    • A61H2201/00Characteristics of apparatus not provided for in the preceding codes
    • A61H2201/16Physical interface with patient
    • A61H2201/1657Movement of interface, i.e. force application means
    • A61H2201/1664Movement of interface, i.e. force application means linear
    • A61H2201/1669Movement of interface, i.e. force application means linear moving along the body in a reciprocating manner
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61HPHYSICAL THERAPY APPARATUS, e.g. DEVICES FOR LOCATING OR STIMULATING REFLEX POINTS IN THE BODY; ARTIFICIAL RESPIRATION; MASSAGE; BATHING DEVICES FOR SPECIAL THERAPEUTIC OR HYGIENIC PURPOSES OR SPECIFIC PARTS OF THE BODY
    • A61H2201/00Characteristics of apparatus not provided for in the preceding codes
    • A61H2201/50Control means thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61HPHYSICAL THERAPY APPARATUS, e.g. DEVICES FOR LOCATING OR STIMULATING REFLEX POINTS IN THE BODY; ARTIFICIAL RESPIRATION; MASSAGE; BATHING DEVICES FOR SPECIAL THERAPEUTIC OR HYGIENIC PURPOSES OR SPECIFIC PARTS OF THE BODY
    • A61H2205/00Devices for specific parts of the body
    • A61H2205/08Trunk
    • A61H2205/087Genitals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61HPHYSICAL THERAPY APPARATUS, e.g. DEVICES FOR LOCATING OR STIMULATING REFLEX POINTS IN THE BODY; ARTIFICIAL RESPIRATION; MASSAGE; BATHING DEVICES FOR SPECIAL THERAPEUTIC OR HYGIENIC PURPOSES OR SPECIFIC PARTS OF THE BODY
    • A61H2230/00Measuring physical parameters of the user
    • A61H2230/50Temperature
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61NELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N5/00Radiation therapy
    • A61N5/06Radiation therapy using light
    • A61N5/0601Apparatus for use inside the body
    • A61N5/0603Apparatus for use inside the body for treatment of body cavities
    • A61N2005/0608Rectum
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61NELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N5/00Radiation therapy
    • A61N5/06Radiation therapy using light
    • A61N5/0601Apparatus for use inside the body
    • A61N5/0603Apparatus for use inside the body for treatment of body cavities
    • A61N2005/0611Vagina
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61NELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N5/00Radiation therapy
    • A61N5/06Radiation therapy using light
    • A61N2005/0658Radiation therapy using light characterised by the wavelength of light used
    • A61N2005/0659Radiation therapy using light characterised by the wavelength of light used infrared

Definitions

  • the present invention generally relates to a method of applying laser energy as a treatment regimen to the vagina or rectum. More specifically, the present invention relates to a method of transmitting laser energy across vaginal and or rectal tissue to treat the causes and symptoms of chronic pelvic pain, chronic prostatitis, and overactive bladder.
  • Pelvic disorders such as chronic pelvic pain and chronic prostatitis are highly prevalent and highly debilitating. Over 50 million U.S. women and over 100 million women worldwide suffer from chronic pelvic pain. In the absence of readily available and effective treatments, only 40% of chronic pelvic pain patients are referred to specialists. Over 8 percent of men suffer from chronic prostatitis. This is a prevalence similar to diabetes and heart disease. Similar to chronic pelvic pain, there are few effective treatments. Up to 90% of men with chronic prostatitis meet the criteria for chronic nonbacterial prostatitis/chronic pelvic pain syndrome, a disorder with few treatment options supported by only limited evidence. Although approximately 16% of men and women suffer from the symptoms of overactive Bladder, multiple treatments are available.
  • Existing treatments for overactive Bladder include prescription medications taken in perpetuity, with numerous side effects, repetitive injections of botulinum toxin with associated side effects and only transient improvement, implantable neuromodulation devices costing fifteen to twenty thousand dollars per implant, and repetitive percutaneous nerve stimulation. There are no non- systemic, non-invasive treatments for overactive bladder symptoms.
  • the present invention comprises an apparatus and method that have one or more of the following features and/or steps, which alone or in any combination may comprise patentable subject matter. [008]
  • the present invention overcomes the shortcomings of the prior art in that it provides a non-invasive method for treating the above identified conditions that is safe and effective.
  • a method for treating pelvic pain and or chronic prostatitis, and or overactive bladder symptoms by way of the trans-tissue transmission of laser energy preferably in the infrared or near infrared spectrum
  • the method comprises the steps of providing a probe capable of emitting said energy to and through the vaginal and or rectal tissue, inserting said probe into the vagina and or rectum, and activating the source of the energy.
  • the probe is thence kept in continuous, back and forth, motion until the appropriate dose of energy has been administered.
  • FIG. 1 depicts an exemplary flow chart for the first embodiment of the method of the invention for treating the vagina of a patient.
  • Fig. 2 depicts a laser source and probe system such as may be utilized in carrying out the steps of the invention.
  • Fig. 3A depicts a probe apparatus such as may be utilized in carrying out the steps of the invention, depicting a probe with a bulbous or spherical massaging light emitting portion and depicting an exemplary radiation pattern.
  • Fig. 3B depicts an exemplary cross section of the probe depicted in Fig. 3A.
  • FIGs. 4A and 4B depicts a conical embodiment of probe apparatus such as may be utilized in carrying out the steps of the invention.
  • Figs. 5A and 5B depicts a trapezoidal embodiment of probe apparatus such as may be utilized in carrying out the steps of the invention.
  • Fig. 6 depicts a generalized probe apparatus such as may be utilized in carrying out the steps of the invention for use in treating vaginal tissue, depicting energy radiating from the probe in a direction along a longitudinal axis of the probe in a spherical or partially spherical pattern.
  • Fig. 7 depicts a probe apparatus such as may be utilized in carrying out the steps of the invention, depicting the probe inserted just beyond the opening of the vagina of a patient, and showing laser energy emitted from the probe.
  • Fig. 6 Further depicts a probe apparatus such as may be utilized in carrying out the steps of the invention, depicting the probe inserted into the vagina of a patient, depicting the vaginal tissue conforming to the bulbous tip of the probe, and depicting the total distance of travel L of the laser probe within the vagina for an embodiment of the method of the invention.
  • Figs. 8A and 8B depict a generalized probe apparatus such as may be utilized in carrying out the steps of the invention for use in treating the prostate, depicting energy radiating from a side of the probe in a direction transverse to a longitudinal axis of the probe so as to illuminate the length of the tissue overlying the prostate.
  • Fig. 8A depicts a side view
  • Fig. 8B depicts an end view.
  • Fig. 9 depicts a probe apparatus such as may be utilized in carrying out the steps of the invention for use in treating the prostate, depicting the probe in relation to the rectum walls, and depicting the rectum walls conforming around the bulbous tip of the probe.
  • Fig. 9 further depicts the probe inserted into the rectum at the point to the point where the first (proximal) mark is located at the anus, at which point the laser energy source may be activated and deactivated.
  • Fig. 9 also depicts and further depicts the probe inserted into the rectum to the point where the second (distal) mark is located at the anus marks on the probe.
  • Fig. 10 depicts an exemplary pulsatile waveform of an embodiment of the method of the invention.
  • Fig. 11 depicts an embodiment of a probe of the invention, showing embodiment of a temperature sensor disposed on the probe for measuring the temperature of body tissue.
  • Fig. 12a depicts an embodiment of a probe of the invention for vaginal use, in which the massaging portion and the light emitting portion are separated by a distance Z.
  • Fig. 12b depicts an embodiment of a probe of the invention for rectal use, in which the massaging portion and the light emitting portion are separated by a distance Z.
  • Fig. 13 depicts a block diagram of an embodiment of the temperature probe and laser source controller of the invention.
  • memory “medium”, “media”, “computer readable memory”, “computer readable medium”, “storage media”, “computer readable storage media” and “computer readable storage medium” shall include within their meanings only physical non-transitory computer readable hardware, and such terms shall specifically exclude signals per se, carrier waves, propagating signals and other transitory signals.
  • Such physical non transitory computer readable media may comprise hardware memory that comprises a physical structure for storing data which may include computer executable instructions or data.
  • controller includes within its meaning any electrical device or combination of electrical devices capable of executing computer readable instructions such as a controller, processor, microcontroller, microprocessor, field programmable gate array, programmable logic array, embedded firmware, virtual machine, combinational logic or any other electrical or electronic device or any combination of devices known in the electrical arts as capable of executing computer readable or hardcoded instructions.
  • controller includes within its meaning that the controller executes computer readable non-transitory or hardcoded instructions, or utilizes hardwired logic or any other means known in the art for controlling a feature, device, or signal, to carry out the subject function.
  • controller Any function herein described as being caused or commanded by the controller of the invention may be carried out by the controller executing computer readable non-transitory instructions, or utilizing hardwired logic, programmable logic such as gate arrays, or any other means known in the art for controlling a feature, device, or signal, to carry out the subject function
  • near infrared means between 700nm and l,400nm.
  • Power and energy density measurements are referenced to the surface of the probe light emitting portion 101 (or 101a, 101b, 101c, etc.).
  • the power or energy density given is an average power density as measured across the total surface area emitting the laser energy.
  • Each of the preferred embodiments of the treatment method of the invention may share the clinically effective novel dosing regimen and parameters of the invention that were discovered and developed only through the extensive experimentation by the inventor, including multiple clinical trials.
  • the experimentation led to a determination of the specific claimed treatment parameters that were observed to be efficacious when laser energy was applied to body tissue using a probe in the manner described herein.
  • These novel dosing and treatment parameters comprise the administration of light energy at of 4-10 watts for vaginal use and 2-8 watts for rectal use; the administration of between 2000 and 4000 joules of near infrared light per treatment; the administration of such energy at a power density between .09 W/cm 2 and 6.0 W/cm 2 measured at the exterior surface of the light emitting portion of the laser probe; and the movement of the probe along the treatment area at a rate between 2.5 millimeters per second and 60 millimeters per second to provide both a massaging and an irradiating effect.
  • the power density (W/cm 2 ) to probe speed ratio shall (mm/sec) was experimentally determined to be between .0042 and 1.8. Outside this range, therapeutic effect was lost.
  • the method of the invention comprises, generally, the steps of providing a source of laser energy 500, providing a probe 001 capable of emitting laser energy to body tissue such as vaginal tissue or rectal tissue, probe 001 being in optical communication with said source of laser energy 003 via optical fiber or cable 004, and probe body portion 100 which attaches probe portion 101 to probe handle 002.
  • Handle 002 may be any apparatus that is adapted to advance or retract, or both, probe body portion 100 in the direction of arrows G and G' which are oriented along an axis of the probe.
  • probe 001 which comprises a probe body portion 100 and a probe massaging portion 101, may be any probe capable of emitting laser energy at near infrared wavelengths.
  • probe massaging portion 101 may be the portion of the probe that emits light energy.
  • these features it is preferred, but not necessary, that these features be located along the probe within one centimeter of each other so that the illumination of body tissue with near infrared light from the light emitting portion of the probe is simultaneously, or nearly simultaneously, receiving a massaging effect by the translation of the probe massaging portion 101 along the treated tissue.
  • the light emitting portion is defined as being a separate structure from the massaging portion such as depicted in Figs. 12A and 12B.
  • the method further comprises the step of inserting the probe into body tissue such as the vagina or rectum of a person, who may be a patient receiving treatment, 502, such that at least a portion of the probe is in physical contact with a portion of said body tissue, followed by the step of activating the source of laser energy 503.
  • the probe may then be translated according various embodiments of the invention to provide a massaging effect on the vaginal or rectal tissue 504, or until a specific treatment parameter has been reached, 505, or both.
  • a laser source and probe system such as may be utilized in carrying out the steps of the invention is depicted.
  • the probe may, by way of example and not by limitation, be laser probes such as the exemplary embodiments of probes depicted in Figs. 3A, 3B, 4A, 4B, 5A and 5B. While these exemplary shapes are depicted, it is understood that the scope of the invention includes any shape for which a massaging portion 101 of the probe is of greater outer dimension than probe body portion 100.
  • Probe body portion 100 has outer dimension B and communicates laser energy from laser source 003 (not shown in Figs. 3A and 3B, but depicted in Fig. 2) to probe light emitting portion 101, which is, in the embodiment depicted, a spherical or bulbous shape of radius R.
  • laser source 003 not shown in Figs. 3A and 3B, but depicted in Fig. 2
  • probe light emitting portion 101 which is, in the embodiment depicted, a spherical or bulbous shape of radius R.
  • probe 001 may be translated a distance L, measured as depicted in the figure.
  • Light energy C may be projected outwards from massaging portion 101 in a substantially or partially spherical pattern, except for the area of the sphere attached to probe connector 100 which may be of outer dimension B as is further discussed in relation to Fig. 6 below.
  • Probe body portion 100 has outer dimension B and communicates laser energy from laser source 003 (not shown in Figs. 4A and 4B, but depicted in Fig. 2) to probe light emitting portion 101, which is, in the embodiment depicted, a conical shape having an end face of radius R.
  • laser source 003 not shown in Figs. 4A and 4B, but depicted in Fig. 2
  • probe light emitting portion 101 which is, in the embodiment depicted, a conical shape having an end face of radius R.
  • probe 001 may be translated a distance L, measured as depicted in the figure.
  • Light energy C may be projected outwards from massaging portion 101, except for the area of the massaging portion attached to probe body portion 100 which may be of outer dimension B.
  • Probe body portion 100 has outer dimension B and communicates laser energy from laser source 003 (not shown in Figs. 5A and 5B, but depicted in Fig. 2) to probe light emitting portion 101, which, in the embodiment depicted, has an outer dimension characterized by radius R.
  • probe 001 may be translated a distance L, measured as depicted in the figure.
  • Light energy C may be projected outwards from massaging portion 101, except for the area of the massaging portion attached to probe body portion 100 which may be of outer dimension B.
  • the light emitting portion and the massaging portion are the same structure 101a, b, or c respectively.
  • outer shape W of probe massaging portion 101 is depicted in broken lines to indicate that the probe massaging portion 101 may be spherical, conical, trapezoidal or any three dimensional shape.
  • spherical, conical, and trapezoidal shapes are described herein as examples of the shape of the massaging portion 101, it is understood that the scope of the invention includes any shape for which outer dimension P is greater than dimension B, i.e., for which the massaging portion of the probe is of greater outer dimension than the probe body portion 100.
  • light is emitted in a radiation pattern that ranges from partially spherical as depicted by angle T-T which may be for example 120°, to nearly spherical as depicted by angle U-U, and having an axis that is coaxial with the longitudinal axis A of the probe.
  • nearly spherical means a radiation pattern that is spherical except for the partially spherical angle depicted as V-V in which little or no light may be transmitted due to probe body portion 100 having an outer dimension B.
  • V-V partially spherical angle depicted as V-V in which little or no light may be transmitted due to probe body portion 100 having an outer dimension B.
  • the value of partially spherical angle V-V is dependent upon the value of B.
  • the radiation pattern thus described causes the treatment of the vaginal walls encountered during energy transmission without the need for rotation of the probe in order to fully illuminate the treated vaginal walls.
  • the center of the radiation pattern may be along an axis that is transverse to the longitudinal axis of the probe A.
  • treatment could be limited to the rectal or bladder side of the vagina and such side could be treated without rotation of the probe.
  • the method of the invention is directed to treating vaginal tissue.
  • the laser probe massaging portion 101 (depicted for example as a spherical massaging portion 101a) is inserted into a vagina in the direction of arrow G, the source of laser energy is activated such that either continuous wave or pulsatile laser energy is transmitted from the laser source, through the probe body portion 100, and into the surrounding vaginal tissue thus treating this tissue.
  • the laser probe massaging portion 101 may then may be translated along the probe longitudinal axis A (not shown in Fig. 6 but shown in Fig.
  • Probe body portion 100 is depicted for reference. Certain anatomical structures, including the bladder, rectum and uterus, are also depicted for reference.
  • Fig. 6 depicts a probe comprising a spherical or bulbous massaging portion 101a, any shape probe may be used.
  • the back and forth motion of the probe over distance L between positions D and E may be, and is preferably, continuous. Continuous is defined as back and forth movement that is interrupted in the instant of a change in direction when the probe has traversed distance L and is located at either proximal position D or distal position E such as is created by an in and out, back and forth, or to and fro movement.
  • This movement of the probe within the vagina creates a mechanical massage effect on the vaginal tissue that is in physical contact with massaging portion 101.
  • These treatment parameters include movement of the probe at a rate between 2.5 millimeters per second and 60 millimeters per second, a total dose of 200-600 joules per linear centimeter of vagina treated or 13.045-310.546 joules/cm 2 , whereas such area is calculated using the linear distance of vagina treated and the radius of the energy emitting portion of the probe, and a power density is between .09 W/cm 2 and 6.0 W/cm 2 .
  • the diameter of the energy emitting portion of the probe is between 1.5 and 3.5 cm
  • the probe velocity is between 10 mm/sec and 40mm/sec
  • the power density (W/cm 2 ) to probe speed (mm sec) ratio shall be between .0042 and 1.8
  • total dose is 200 - 400 joules per linear centimeter or 21.068- 149.208 joules/cm2
  • the power density between .09 W/cm 2 and 6.0 W/cm 2 .
  • Distance L is defined as the distance between the most proximal and most distal points of treatment.
  • the energy source is capable of recording and or otherwise utilizing the linear distance, such information shall be measured and entered in to the energy source prior to the transmission of laser energy through the probe.
  • dosing by joules/cm 2 it is important to understand that the vagina exists as a potential space rather than an open space. Once a probe is placed into the vagina, the potential space is opened, the vaginal tissue conforms around the probe, and the diameter of the space thence becomes the diameter of the inserted probe.
  • This Probe Treatment Surface Area, PTSA has not been previously described, creates an objective measurement allowing for a reproducible treatment protocol with resultant reproducible safety and efficacy.
  • the energy is transmitted in a pulsatile or continuous fashion until a total dose of 200-600 joules per linear centimeter or 13.045-310.546 joules/cm 2 of energy has been transmitted into vaginal tissue, wherein such area is calculated using the linear distance of vagina treated and the radius of the energy emitting portion of the probe, and a power density is between .09 W/cm 2 and 6.0 W/cm 2 .
  • This is the therapeutic range shown to be safe, comfortable, and effective through extensive experimentation.
  • the diameter of the energy emitting portion of the probe is between 1.5 and 3.5 cm
  • the power density (W/cm 2 ) to probe speed (mm/sec) ratio is between .0042 and 1.8
  • total dose is 200 - 400 joules per linear centimeter or 21.068-149.208 joules/cm 2
  • the power density is between .09 W/cm2 and 6.0 W/cm 2 .
  • the probe projects said energy in in a 120-360 degree partially spherical to nearly spherical radiation pattern having an axis that is co-axial with probe longitudinal axis A as depicted in Fig. 6 and described above in relation thereto.
  • the energy source 003 is activated and laser energy is preferably transmitted though the probe massaging portion 101 or light emitting portion 102a as shown in Fig. 12A and into the vaginal tissue surrounding the probe.
  • Distance L is defined as the distance between the most proximal and most distal points of treatment.
  • the laser energy source 003 is then inactivated and the probe is advanced or withdrawn within the vagina by one centimeter. This advancement or withdrawal may be facilitated by markings on probe body portion 100 that are visible from outside the vagina when the probe is inserted into the vagina. This process is repeated until the vaginal canal or painful area of the pelvic floor is fully treated; i.e., until one of the dosage parameters has been met.
  • the energy source is then deactivated and the probe is removed from the vagina.
  • the vaginal treatment methods of the invention may be facilitated by a group of novel device features.
  • Such features include markings on the probe connector portion 100 to demonstrate distance of insertion and a temperature sensor on the probe which provides feedback to the energy source.
  • the energy source adjusts pulse shape and/or amplitude and or time between pulses in order to maintain surface temperature between 40 and 45 degrees centigrade.
  • the energy source shall adjust pulse shape and/or amplitude and or time between pulses in order to maintain surface below 45 degrees centigrade. Auditory and or visual cues may be provided by the energy source user interface and or other hardware to facilitate the movement of the probe at the prescribed rate.
  • Such ques may rely upon the input of the probe diameter or power density information into the energy source and or an accelerometer contained within the probe or handle of the probe. Such cues may also rely upon surface temperature measurements taken by a temperature measuring mechanism within the probe that provides such temperature measurement to the energy source and or accessory hardware.
  • the probe shall have a variation in outside dimension of any cross sectional shape such that a massage or milking effect is created on the treated tissue.
  • this alteration in probe outer dimension may take a spherical shape (see Figs. 3A and 3B), conical shape (see Figs. 4A and 4B), or trapezoidal shape (see Figs. 5A and 5B).
  • the shape of the probe massaging portion outer surface 101 may take any three dimensional shape; the example shapes depicted in Figs. 3A, 3B, 4A, 4B, 5A, and 5B are exemplary and not exhaustive.
  • the method of the invention is directed to treating a prostate by irradiating through the rectum wall into the prostate.
  • This embodiment of the invention involves the placement of a probe of the invention attached to an energy source capable of transmitting continuous wave or pulsatile near infrared wavelengths though said probe, into the rectum, by inserting probe massaging portion 201 into the rectum in the direction of arrow G.
  • the probe is adapted such that it projects said laser energy in a partially spherical radiation pattern having an axis N as shown in Figs.
  • the probe is oriented such that the emitted laser energy is projected predominantly toward the prostate, the energy source is activated and, thence, laser energy is transmitted though the probe and into the surrounding rectal tissue, passing through the rectal tissue and into the prostate.
  • the proper orientation of the probe may be facilitated by a mark on the handle of the probe or a shape of the handle probe that allows the surgeon or other person performing the method of the invention to align the transmitted optical energy from the probe in the direction of the prostate.
  • the probe is then translated in a back and forth motion over a distance L between positions J and R until specified parameters are achieved.
  • Treatment parameters include movement of the probe at a rate between 2.5 millimeters per second and 60 millimeters per second, a total dose of 200-600 joules per linear centimeter of rectum treated or 13.045-310.546 joules/cm 2 , whereas such area is calculated using the linear distance of rectum treated and the radius of the energy emitting portion of the probe, and a power density is between .09 W/cm 2 and 6.0 W/cm 2 .
  • the diameter of the energy emitting portion of the probe shall be between 1.5 and 3.5 cm
  • the probe speed shall be between 10 mm/sec and 40mm/sec
  • the power density shall be between .09 W/cm 2 and 6.0 W/cm 2
  • the power density (W/cm 2 ) to probe speed ratio between .0042 and 1.8
  • total dose shall equal 200 - 400 joules per linear centimeter or 21.068-149.208 joules/cm 2
  • the power density shall be between .09 W/cm 2 and 6.0 W/cm 2 .
  • the distance L is defined as the distance between the most proximal and most distal points of treatment.
  • the energy source is deactivated and the probe is removed from the rectum.
  • the linear distance is that distance beginning one centimeter proximal to the prostate and ending one centimeter distal to the prostate.
  • markings on the probe body portion 100 are used to identify the range of rectum lying beneath and preferably, but not necessarily slightly beyond the margins of the typical prostate and movement occurs between such markings, the linear distance.
  • the distance between such markings may correspond to the length of the prostate to be treated. If the energy source is capable of recording and or otherwise utilizing the linear distance, such information shall be measured and entered in to the energy source prior to the transmission of laser energy through the probe.
  • such energy may emitted by the massaging portion of the probe until a total dose of 200-600 joules per linear centimeter or 13.045- 310.546 joules/cm 2 of energy has been emitted from the probe, wherein such area is calculated using the linear distance of rectum treated and the radius of the energy emitting portion of the probe, and a power density is between .09 W/cm 2 and 6.0 W/cm 2 . This is the therapeutic range shown to be safe through extensive experimentation.
  • the diameter of the energy emitting portion of the probe shall be between 1.5 and 3.5 cm
  • the power density (W/cm 2 ) to probe speed (mm/sec) ratio shall be between .0042 and 1.8
  • total dose shall equal 200 - 400 joules per linear centimeter or 21.068-149.208 joules/cm 2
  • the power density shall be between .09 W/cm 2 and 6.0 W/cm 2 .
  • Distance L is defined as the distance between the most proximal and most distal points of treatment. The energy source is inactivated and the probe is advanced or withdrawn by one centimeter. This advancement or withdrawal may be facilitated by markings 202 on the probe.
  • the pulse shape and time as well as the time between pulses shall be set to maintain a surface below 45 degrees centigrade.
  • treatment distance L may be defined as extending from between points defined as being disposed beyond a proximal boundary M' of the prostate and distal boundary of the prostate M" by distances K' and K", respectively.
  • K' and K" may each equal one centimeter, and thus the massaging portion may be translated in back and forth fashion along L, treating the prostate and the area that extends on either side of the prostate by one centimeter.
  • Distances K' and K" may take any value.
  • laser energy may be transmitted without translation of the probe over distance L.
  • the probe is adapted to transmit a wide beam of laser energy that covers the entire distance of tissue for which treatment is desired.
  • probe body portion 100 is marked having a marking that, when the marking is at the level of the anus and the energy source is activated, laser energy is transmitted in a continuous or pulsatile fashion until the desired dosing is administered; i.e., the desired dosing parameter is met. The energy source is next inactivated and the probe removed.
  • any of the embodiments directed to a method for treating a prostate may be facilitated by a group of novel device features.
  • Such features include measurement markings upon the probe body portion. Such measurement marking provide the linear distance treated.
  • Such features include markings on the probe body portion representing the range of rectum overlying the typical prostate and one cm marking or other equidistant markings between these markings, and a marking on the handle and or a handle shape that orients the energy, predominantly, toward the prostate.
  • the proximal and distal markings will be such that treatment between said markings results in a linear distance that extends one centimeter distal and one centimeter proximal to the prostate location above the rectum.
  • a marking on the handle of the probe may facilitate orientation of the probe such that energy is transmitted predominantly toward the prostate. Auditory and or visual cues may be provided by the energy source user interface and or other hardware to facilitate the movement of the probe at the prescribed rate. Such cues shall rely upon the input of the probe diameter or power density information into the energy source and or an accelerometer contained within the probe or handle of the probe. Such cues may also rely upon surface temperature measurements taken by a temperature measuring mechanism within the probe that provides such temperature measurement to the energy source or accessory. In the preferred embodiment, the probe massaging portion has a greater outer dimension that the probe body portion such that a massage or milking effect is created.
  • the probe massaging portion may comprise a spherical shape, trapezoidal shape, conical shape or any other shape. Ideally but not necessarily, said probe massaging portion is disposed at or within one cm of the energy emitting area of the probe. A temperature sensor on the probe may provide feedback to the energy source.
  • the pulse shape in any embodiment of the method of the invention using pulsatile laser energy, the pulse shape, meaning amplitude and width, frequency, and time as well as the time between pulses, i.e. duty cycle, may be adapted so as to maintain a probe surface temperature between 40 and 45 degrees centigrade.
  • an exemplary pulsatile waveform is depicted having a period T, a pulse width U, and an amplitude V. Any of these parameters may be changed in order to maintain a probe surface temperature between 40 and 45 degrees centigrade or to achieve a desired power or applied energy per linear centimeter, power or applied energy per square centimeter, or total applied energy.
  • the duty cycle of the pulsatile waveform is defined as the pulse width U, measured in units of time, divided by the waveform period T, measured in units of time.
  • the desired treatment parameters may be any of the following, either alone or in any combination: 1) the administering of between 2000 4000 joules to the treatment area; 2) the administering of between 200-600 joules per linear centimeter to the treatment area; 3) the administering of between 21.068-149.208 joules/cm 2 to the treatment area; 4) or the administering of between 13.045-310.546 joules/cm 2 to the treatment area.
  • the massaging portion and the light emitting portion may be fabricated from any material that is transmissive at near infrared wavelengths, such as silica glass, plastic, or any other material that is transmissive to laser energy over the defined near infrared wavelength range.
  • the probe light emitting portion and massaging portion 101 may be the same structure, as depicted in Figs. 3A, 3B, 4A, 4B, 5A and 5B.
  • a temperature sensor 301 and connecting wiring 300 is depicted in Fig. 11.
  • Temperature sensor 301 may be connected to a controller 350 via wiring 300 as is further described in relation to the exemplary electrical block diagram of Fig. 13.
  • Temperature sensor 301 may comprise any temperature sensor known in the art.
  • temperature sensor 301 may comprise a thermistor, semiconductor device, or any other electrical device that exhibits a change in at least one electrical characteristic proportional to, or in a known relationship to, changes in temperature.
  • Temperature sensor 301 may comprises a thermally conductive element that is in physical contact with at least a portion of the tissue near the light emitting element of the probe, such that when the tissue changes temperature, the at least one electrical characteristic of the temperature probe also changes in a known relationship with the change in tissue temperature.
  • Temperature probe 301 may be in communication with controller 350 (shown in Fig. 13). Controller 350 is adapted to measure the change in the at least one electrical characteristic of the temperature probe, and thereby is able to estimate the temperature of the tissue. Using this information, Controller 350 may then command the laser energy source 003 to either provide more or less power to achieve a particular tissue temperature, or to keep the tissue between a lower and upper limit of temperature.
  • the temperature sensor may be comprised of an alexandrite fluorescence lifetime fiber optic thermometer in communication with controller 350.
  • Probe body outer dimension B is shown for reference, as is probe longitudinal axis A and laser energy C being emitted massaging body 101a.
  • the massaging portion and the light emitting portion are the same structure and may be fabricated from any material that is transmissive at near infrared wavelengths, such as silica glass, plastic, or any other material that is transmissive to laser energy over the defined near infrared wavelength range.
  • Probe body 100 may comprise markings 202 at specific intervals, for example one centimeter spacing, to assist a surgeon with translating the probe over a predetermined linear distance.
  • the probe comprises a body portion 100, a light emitting portion 102a and a massaging portion 101a wherein light emitting portion is transmissive to near infrared laser energy; and wherein the probe is capable of being in optical communication with a source of laser energy 003 such that laser energy is transmissible from the laser source 003, through the body portion and into said light emitting portion 102a.
  • the light emitting portion 102a is capable of emitting the laser energy C into tissue surrounding light emitting portion 102a when said laser source 003 is activated.
  • the massaging portion 101a has an outer dimension D that is larger than the body portion outer dimension B.
  • the probe configuration shown in Fig. 12A may be used to treat any body tissue but is also specifically adapted to emit laser energy C into vaginal tissue.
  • Laser energy C may be emitted in a partially spherical radiation pattern as depicted in angles T-T and U-U in Fig. 6, wherein the spherical pattern is centered around an axis that is coaxial with the longitudinal axis of the probe A.
  • Probe body 100 may comprise markings 202 at specific intervals, for example one centimeter spacing, to assist a surgeon with translating the probe over a predetermined linear distance.
  • temperature sensor 301 may be in communication with controller 350 for measuring tissue temperature and controlling laser source 003 parameters, such as output power or duty cycle, or both, to achieve a desired tissue temperature range.
  • the light emitting portion 102a and the massaging portion 101a are separated by a distance Z as measured from the center of laser energy C emission from the light emitting portion 102a to the nearest surface of massaging portion 101a.
  • An exemplary value for Z is one to two centimeters, but any other desired value for Z may be used.
  • Massaging portion 101a is depicted as being spherically shaped in Fig.
  • the embodiments of the probe in which the massaging portion 101 is not the same structure as the light emitting portion may comprise any outer shape (e.g. spherical, conical, trapezoidal, or otherwise) for the massaging portion 101 or light emitting portions 102a.
  • the probe comprises a body portion 100, a light emitting portion 102a and a massaging portion 101a wherein light emitting portion is transmissive to near infrared laser energy; and wherein the probe is capable of being in optical communication with a source of laser energy 003 such that laser energy is transmissible from the laser source 003, through the body portion 100 and into the light emitting portion 102a.
  • the light emitting portion 102a is capable of emitting the laser energy C into tissue surrounding light emitting portion 102a when said laser source 003 is activated.
  • the massaging portion 101a has an outer dimension D that is larger than the body portion outer dimension B.
  • the probe configuration shown in Fig. 12B may be used to treat any body tissue but is also specifically adapted to emit laser energy C into rectal tissue.
  • Laser energy C may be emitted in a partially spherical radiation pattern as depicted in angles in Figs. 8A and 8B, wherein the spherical pattern is centered around an axis N that is orthogonal to the longitudinal axis of the probe A.
  • Probe body 100 may comprise markings 202 at specific intervals, for example one centimeter spacing, to assist a surgeon with translating the probe over a predetermined linear distance.
  • temperature sensor 301 may be in communication with controller 350 for measuring tissue temperature and controlling laser source 003 parameters, such as output power or duty cycle, or both, to achieve a desired tissue temperature range.
  • the light emitting portion 102a and the massaging portion 101a are separated by a distance Z as measured from the center of laser energy C emission from the light emitting portion 102a to the nearest surface of massaging portion 101a.
  • An exemplary value for Z is one to two centimeters.
  • Massaging portion 101a is depicted as being spherically shaped in Fig. 12B, but the embodiments of the probe in which the massaging portion 101 is not the same structure as the light emitting portion may comprise any outer shape (e.g. spherical, conical, trapezoidal, or otherwise) for the massaging portion 101 or light emitting portions 102a.
  • a temperature measuring element 301 may be located on the probe as depicted, by way of example, in Figs. 11, 12A and 12B.
  • the temperature measuring element 301 may be any element for sensing a temperature and producing a signal proportional to the temperature, or which exhibits a change in electrical characteristic proportional to, or in a known relationship to, changes in temperature.
  • Temperature sensing element 301 may comprise a thermally conductive element that is in physical contact with at least a portion of the tissue near the light emitting element of the probe, such that when the tissue changes temperature, the at least one electrical characteristic of the temperature probe also changes in a known relationship with the change in tissue temperature.
  • temperature sensing element 301 may comprise a digital thermometer circuit that produces a digital output that is coded to represent the temperature of the measured tissue.
  • Temperature probe 301 may be in communication with controller 350.
  • Controller 350 is adapted to measure the change in the at least one electrical characteristic of the temperature probe, and thereby is able to estimate the temperature of the tissue.
  • controller 350 when controller 350 is a device that is adapted to perform functions by the execution of non-transitory computer readable instructions, such instructions may be stored in computer readable media (CRM) 351 that is in communication with controller 350.
  • Controller 350 may read and execute the non transitory instructions stored in CRM 352 to perform the processing of the temperature signal from temperature sensing element 301 Using this information.
  • Controller 350 may then command the laser energy source 003 to either provide more or less power to achieve a particular tissue temperature, or to keep the tissue between a lower and upper limit of temperature. This may be done by controller 350 directly controlling the output power or duty cycle of laser energy source 003, or by commanding an intervening laser drive circuit 352 is a controllable circuit adapted to receive a control signal from controller 350 and to control the output power or duty cycle of laser energy source.
  • laser energy source 003 provides laser energy to the probe through an optically transmissive path, which may be, for example, an optical fiber that is transmissive at near infrared wavelengths.
  • Temperature sensing element 301 is in at least temporary physical contact with the tissue near to or surrounding the probe massaging portion. Temperature sensing element 301 provides a signal proportional to the temperature of the tissue as hereinbefore described, and controller 350 may then execute non-transitory computer readable instructions for reading the temperature of said tissue and controlling said laser drive circuit in order to adjust a laser source parameter selected from the group consisting of amplitude and duty cycle in order to maintain said tissue at a temperature between 40° and 45° centigrade, or any other temperature range desired or predetermined.

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pathology (AREA)
  • Radiology & Medical Imaging (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Reproductive Health (AREA)
  • Epidemiology (AREA)
  • Pain & Pain Management (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Rehabilitation Therapy (AREA)
  • Physics & Mathematics (AREA)
  • Optics & Photonics (AREA)
  • Otolaryngology (AREA)
  • Radiation-Therapy Devices (AREA)
EP17899773.0A 2017-03-08 2017-03-08 Verfahren zur behandlung von beckenschmerzen, chronischer prostatitis und/oder symptomen einer überaktiven blase Pending EP3592423A4 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/US2017/021273 WO2018164676A1 (en) 2017-03-08 2017-03-08 Method for treating pelvic pain, chronic prostatitis, and or overactive bladder symptoms

Publications (2)

Publication Number Publication Date
EP3592423A1 true EP3592423A1 (de) 2020-01-15
EP3592423A4 EP3592423A4 (de) 2021-03-10

Family

ID=63448866

Family Applications (1)

Application Number Title Priority Date Filing Date
EP17899773.0A Pending EP3592423A4 (de) 2017-03-08 2017-03-08 Verfahren zur behandlung von beckenschmerzen, chronischer prostatitis und/oder symptomen einer überaktiven blase

Country Status (3)

Country Link
EP (1) EP3592423A4 (de)
CN (1) CN109069857A (de)
WO (1) WO2018164676A1 (de)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11896823B2 (en) 2017-04-04 2024-02-13 Btl Healthcare Technologies A.S. Method and device for pelvic floor tissue treatment
CN111445754B (zh) * 2020-04-30 2023-04-07 中国医学科学院生物医学工程研究所 一种模拟激光外科手术的辅助训练系统
RU2766778C1 (ru) * 2021-11-11 2022-03-15 Федеральное государственное бюджетное учреждение "Национальный медицинский исследовательский центр колопроктологии имени А.Н. Рыжих" Министерства здравоохранения Российской Федерации Способ лечения нейрогенной хронической тазовой боли

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1094275A (zh) * 1993-04-20 1994-11-02 郝宗超 直肠内水囊式热按摩仪
CN1498600A (zh) * 2002-11-04 2004-05-26 中国科学院福建物质结构研究所 一种肿瘤激光热疗仪
EP1684866A1 (de) * 2003-11-14 2006-08-02 Kim, Jin-il Medizinprodukt zur behandlung von prostaterkrankungen mit nah-infrarot-led
EP1871476B1 (de) * 2005-03-31 2018-01-03 Esther Mayer Sondenvorrichtung für die photobiomodulation von gewebe, das eine körperhöhle auskleidet
KR20070106872A (ko) * 2006-05-01 2007-11-06 김진일 발광다이오드 또는 레이저다이오드를 이용한 전립선 및회음부 치료기
US20170172658A1 (en) * 2008-07-01 2017-06-22 Ralph Zipper Method for treating pelvic pain, chronic prostatitis, and or overactive bladder symptoms
US20110004203A1 (en) * 2009-07-01 2011-01-06 Ralph Zipper Laser Device and Method for Decreasing the Size and/or Changing the Shape of Pelvic Tissues
US20100286576A1 (en) * 2009-05-06 2010-11-11 Bwt Property, Inc. Photo Therapy and Massage Apparatus for Relieving Pain in Body Cavities
IT1405000B1 (it) * 2010-02-04 2013-12-16 El En Spa Dispositivo per il trattamento del canale vaginale e relativo apparecchio
US8574177B2 (en) * 2010-03-11 2013-11-05 Bwt Property, Inc. Phototherapy and massage apparatus for treating medical conditions in body cavities
US20120253204A1 (en) * 2010-03-17 2012-10-04 Photopill Medical Ltd. Systems and methods for phototherapeutic treatment of rectal diseases
US9011316B2 (en) * 2011-11-04 2015-04-21 Ohmea Medical Technologies, Inc. Systems and methods for therapeutic treatments of various conditions of a female person
US10413473B2 (en) * 2012-03-14 2019-09-17 Ralph Zipper Sexual stimulation device using light therapy, vibration and physiological feedback
US9949889B2 (en) * 2013-11-11 2018-04-24 Joylux, Inc. At-home light-emitting diode and massage device for vaginal rejuvenation

Also Published As

Publication number Publication date
EP3592423A4 (de) 2021-03-10
CN109069857A (zh) 2018-12-21
WO2018164676A1 (en) 2018-09-13

Similar Documents

Publication Publication Date Title
US20190125448A1 (en) System and method for applying controlled dosage light therapy for treatment of body tissue
US20240216681A1 (en) Method and device for pelvic floor tissue treatment
US10039929B1 (en) Method and device for pelvic floor tissue treatment
JP4633050B2 (ja) 出力規制された医療用皮膚下照射治療装置
ES2972602T3 (es) Terapia de ultrasonido con transductor de banda
JP5535225B2 (ja) 甲状腺および副甲状腺を超音波治療するためのシステムおよび方法
EP2073739B1 (de) Venenbehandlungsvorrichtung
JP2012519554A (ja) 熱的外科手術安全装置および熱的外科手術方法
US20100298744A1 (en) System and method of treating tissue with ultrasound energy
US20150305811A1 (en) Device and method for laser treatments
KR102428353B1 (ko) 고강도 집속 초음파 시술 장치 및 그 시술 방법
US20170172658A1 (en) Method for treating pelvic pain, chronic prostatitis, and or overactive bladder symptoms
JP2012502714A (ja) 処置用量送達手段および用量測定制御手段を実現してヒトまたは動物の身体の一部を処置するための装置および方法
EP3592423A1 (de) Verfahren zur behandlung von beckenschmerzen, chronischer prostatitis und/oder symptomen einer überaktiven blase
CN107427406A (zh) 胶原刺激装置和方法
US20230414299A1 (en) Tissue interface system
EP3325095B1 (de) System zur anwendung einer lichttherapie auf gekrümmte und grosse oberflächen
US20130310715A1 (en) Apparatus for the treatment of hyperhidrosis
US20220257969A1 (en) Method for treating pelvic pain, chronic prostatitis, and or overactive bladder symptoms
US20060212099A1 (en) Optical skin germicidal device and method
KR102591570B1 (ko) 집속 초음파 시술 장치
KR102566620B1 (ko) 광 치료 장치
US20220273367A1 (en) System and method for applying controlled dosage light therapy for treatment of body tissue
KR102591566B1 (ko) 집속 초음파 시술 장치
KR101599253B1 (ko) 관형 신체조직의 진단―치료 겸용 융합형 광 의료기기

Legal Events

Date Code Title Description
STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE INTERNATIONAL PUBLICATION HAS BEEN MADE

PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: REQUEST FOR EXAMINATION WAS MADE

17P Request for examination filed

Effective date: 20190920

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR

AX Request for extension of the european patent

Extension state: BA ME

DAV Request for validation of the european patent (deleted)
DAX Request for extension of the european patent (deleted)
A4 Supplementary search report drawn up and despatched

Effective date: 20210204

RIC1 Information provided on ipc code assigned before grant

Ipc: A61N 5/067 20060101AFI20210129BHEP

Ipc: A61N 5/06 20060101ALI20210129BHEP

Ipc: A61H 21/00 20060101ALI20210129BHEP

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: EXAMINATION IS IN PROGRESS

17Q First examination report despatched

Effective date: 20230419